Prostate Drugs Linked to Cancer Risk

proscar

The U.S. Food and Drug Administration recently revised its warning information for a group of prostate drugs, including GlaxoSmithKline PLC’s Avodart and Merck & Co.’s Proscar, over concerns they may increase the risk of a more serious form of prostate cancer. The warning, which links use of the drugs to a greater risk of developing [...]